BlackRock’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.1M | Buy |
4,165,540
+173,003
| +4% | +$4.08M | ﹤0.01% | 2038 |
|
|
2025
Q1 | $95.9M | Buy |
3,992,537
+51,051
| +1% | +$1.23M | ﹤0.01% | 1993 |
|
|
2024
Q4 | $167M | Buy |
3,941,486
+489,284
| +14% | +$20.7M | ﹤0.01% | 1756 |
|
|
2024
Q3 | $153M | Buy |
3,452,202
+114,530
| +3% | +$5.06M | ﹤0.01% | 1805 |
|
|
2024
Q2 | $121M | Buy |
3,337,672
+18,708
| +0.6% | +$677K | ﹤0.01% | 1902 |
|
|
2024
Q1 | $143M | Buy |
3,318,964
+564,070
| +20% | +$24.3M | ﹤0.01% | 1833 |
|
|
2023
Q4 | $42.4M | Buy |
2,754,894
+396,476
| +17% | +$6.1M | ﹤0.01% | 2539 |
|
|
2023
Q3 | $32.3M | Buy |
2,358,418
+188,284
| +9% | +$2.58M | ﹤0.01% | 2619 |
|
|
2023
Q2 | $34.8M | Buy |
2,170,134
+759,864
| +54% | +$12.2M | ﹤0.01% | 2646 |
|
|
2023
Q1 | $10.9M | Buy |
1,410,270
+534,386
| +61% | +$4.15M | ﹤0.01% | 3194 |
|
|
2022
Q4 | $16.9M | Buy |
875,884
+85,089
| +11% | +$1.65M | ﹤0.01% | 3061 |
|
|
2022
Q3 | $16.9M | Buy |
790,795
+73,761
| +10% | +$1.57M | ﹤0.01% | 3077 |
|
|
2022
Q2 | $9.76M | Buy |
717,034
+37,359
| +5% | +$508K | ﹤0.01% | 3444 |
|
|
2022
Q1 | $16M | Buy |
679,675
+224,575
| +49% | +$5.28M | ﹤0.01% | 3241 |
|
|
2021
Q4 | $12.2M | Buy |
455,100
+141,063
| +45% | +$3.77M | ﹤0.01% | 3495 |
|
|
2021
Q3 | $5.45M | Buy |
314,037
+313,444
| +52,857% | +$5.44M | ﹤0.01% | 3869 |
|
|
2021
Q2 | $8K | Buy |
+593
| New | +$8K | ﹤0.01% | 5281 |
|